Keyphrases
World Health Organization Guidelines
100%
Rheumatic Fever
100%
Rheumatic Heart Disease
100%
World Health Organization
19%
Sanitation
11%
Antibiotic Prophylaxis
11%
Politicians
7%
High Risk
7%
Secondary Prevention
7%
Evidence-informed
7%
Healthcare Workers
7%
New Evidence
7%
Primary Prevention
7%
Program Directors
7%
Throat Infection
7%
Guideline Development
7%
First Episode
7%
Living Conditions
7%
Skin Infection
7%
Access to Clean Water
7%
GAS Infection
7%
Early Intervention
3%
Europe
3%
North America
3%
Primary Care
3%
Peer Review
3%
Preventive Care
3%
Clinical Care
3%
Current Guidelines
3%
Aging
3%
Geneva
3%
High-income Countries
3%
Local Policy
3%
Pharyngitis
3%
Middle-income Countries
3%
Economic Burden
3%
Group A β-hemolytic Streptococcus
3%
Professional Societies
3%
Indigenous Population
3%
Public Health Risk
3%
Local Community
3%
Adaptation
3%
Relevant Evidence
3%
Current Recommendations
3%
Ventilation
3%
New Intervention
3%
Inflammatory Response
3%
Disease Progression
3%
High Prevalence
3%
East Asia
3%
Health Burden
3%
Quality Assurance
3%
Autoimmune
3%
Middle East
3%
Affected People
3%
Functional Change
3%
Poverty
3%
Conflict of Interest
3%
Vulnerable Populations
3%
Secretariat
3%
South Asia
3%
20th Century
3%
Latin America (LATAM)
3%
Sub-Saharan Africa
3%
Local Authorities
3%
Switzerland
3%
Early Reviews
3%
Central Asia
3%
Living Space
3%
Policy Program
3%
Diverse Settings
3%
Social Burden
3%
Equitable Access
3%
Stakeholder Input
3%
Four-level
3%
Disease Onset
3%
Community Leaders
3%
Recurrence Prevention
3%
Guidance Documents
3%
Low-middle Income Countries
3%
Anti-inflammatory Drugs
3%
Anticoagulants
3%
Technical Staff
3%
Long-term Antibiotics
3%
Treatment Services
3%
National Policy
3%
Recurrent Episodes
3%
Newborn Infant
3%
South Pacific
3%
Screening Services
3%
Adolescent Health
3%
High Quality Service
3%
Updated Guidelines
3%
Marginalized Communities
3%
Lifelong Disability
3%
World Regions
3%
Technical Expert
3%
Tertiary Prevention
3%
Maternal Newborn Health
3%
Maternal-child Health
3%
Declaration of Interest
3%
Program Staff
3%
Levels of Prevention
3%
Expert Advisor
3%
Streptococcus Pyogenes (S. pyogenes)
3%
State Program
3%
GAS Pharyngitis
3%
High-income Setting
3%
Cardiac Intervention
3%
Skin Structure Infections
3%
Primordial Prevention
3%
Guideline Development Group
3%
Selected Topic
3%
Medicine and Dentistry
Rheumatic Heart Disease
100%
Rheumatic Fever
100%
Pharyngitis
15%
Prevalence
11%
Antibiotic Prophylaxis
11%
Diseases
7%
Systematic Review
7%
Secondary Prevention
7%
Health Care Personnel
7%
Primary Prevention
7%
Skin Infection
7%
Group A Streptococcal Infection
7%
Public Health
3%
Primary Health Care
3%
Infection
3%
Early Intervention
3%
Prematurity
3%
Recurrent Disease
3%
Serositis
3%
Low and Middle Income Countries
3%
Indigenous Peoples
3%
Autoimmunity
3%
Neonatal Infant
3%
Maternal Health
3%
Antiinflammatory Agent
3%
Crowding (Area)
3%
Anticoagulant
3%
Vulnerable Population
3%
Adolescent Health
3%
Social Health
3%
Beta Hemolytic Streptococcus
3%
Tertiary Prevention
3%
Streptococcus pyogenes
3%
Skin Structure
3%